Farouk Omar, Attia Essam, Roshdy Sameh, Khater Ashraf, Senbe Ahmad, Fathi Adel, Hamed Emad-Eldeen, Mesbah Mahmoud, Shehatto Fayez, El-Saed Aiman, Denewer Adel
Surgical Oncology Department, Oncology Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Community Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
World J Surg Oncol. 2015 Sep 26;13:285. doi: 10.1186/s12957-015-0688-1.
Traditionally, conservative breast surgery was contraindicated in centrally located breast tumors, with total mastectomy as the treatment of choice. However, restorations of the central defects by the oncoplastic volume displacement or replacement techniques have been shown to be effective. The aim of the current study was to assess the surgical outcome of oncoplastic techniques after central breast tumors resection.
Thirty patients with central breast cancer, including two patients with Paget disease, treated at the Oncology Center of Mansoura University (Egypt) between June 2011 and December 2014 were included in this study. The oncoplastic techniques performed were Grisotti advancement rotational flap in eight (26.7%) patients, classic skin-sparing mastectomy (SSM) with latissimus dorsi pedicled flap in 20 (66.7%) patients, and skin-reducing mastectomy (SRM) with latissimus dorsi pedicled flap using wise pattern inverted T incision in two (6.7%) patients. The choice of the oncoplastic techniques depends on the achievement of free safety margins, the breast volume, and its ptotic degree.
The median age was 40.5 years (range; 23-55). There were no major complications that require repeating the oncoplastic techniques. Recorded complications included wound dehiscence (4/30, 13.3%) donor site seroma (4/30, 13.3%), and surgical site infection (1/30, 3.3%). The 6-month subjective patient satisfaction was excellent in 21 (70%) patients, good in 6 (20%) patients, and fair in 3 (10%) patients. There was no episode of local recurrence or systemic metastasis after an average follow-up duration of 24 months (range; 6-42).
Restoring the central defect after resection of the central breast tumors can be safely achieved using oncoplastic procedures including the Grisotti technique or the design of SSM or SRM with immediate breast reconstruction. In our patients, these procedures yield a satisfactory esthetic outcome with lower morbidity.
传统上,位于乳房中央的肿瘤禁忌进行保乳手术,全乳切除术是首选治疗方法。然而,肿瘤整形容积置换或替代技术修复中央缺损已被证明是有效的。本研究的目的是评估中央型乳腺肿瘤切除术后肿瘤整形技术的手术效果。
本研究纳入了2011年6月至2014年12月在曼苏拉大学肿瘤中心(埃及)接受治疗的30例中央型乳腺癌患者,其中包括2例佩吉特病患者。采用的肿瘤整形技术包括:8例(26.7%)患者采用格里索蒂推进旋转皮瓣,20例(66.7%)患者采用经典保留皮肤乳房切除术(SSM)加背阔肌带蒂皮瓣,2例(6.7%)患者采用改良倒T形切口的保留皮肤乳房切除术(SRM)加背阔肌带蒂皮瓣。肿瘤整形技术的选择取决于能否获得足够的安全切缘、乳房体积及其下垂程度。
患者中位年龄为40.5岁(范围23 - 55岁)。没有需要重复肿瘤整形技术的严重并发症。记录的并发症包括伤口裂开(4/30,13.3%)、供区血清肿(4/30,13.3%)和手术部位感染(1/30,3.3%)。6个月时,21例(70%)患者主观满意度为优,6例(20%)患者为良,3例(10%)患者为中。平均随访24个月(范围6 - 42个月)后,无局部复发或远处转移事件。
采用包括格里索蒂技术或SSM或SRM设计并即刻乳房重建的肿瘤整形手术,可安全修复中央型乳腺肿瘤切除术后的中央缺损。在我们的患者中,这些手术能获得令人满意的美学效果且并发症发生率较低。